Gilead Sciences, Inc.GILDNASDAQ
Loading
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q4 2025 | -28.46% |
| Q3 2025 | 56.69% |
| Q2 2025 | 48.11% |
| Q1 2025 | -25.87% |
| Q4 2024 | 43.00% |
| Q3 2024 | -22.48% |
| Q2 2024 | 138.62% |
| Q1 2024 | -390.43% |
| Q4 2023 | -34.29% |
| Q3 2023 | 108.33% |
| Q2 2023 | 3.70% |
| Q1 2023 | -38.17% |
| Q4 2022 | -8.39% |
| Q3 2022 | 57.14% |
| Q2 2022 | 9379.17% |
| Q1 2022 | -96.80% |
| Q4 2021 | -85.44% |
| Q3 2021 | 70.25% |
| Q2 2021 | -12.32% |
| Q1 2021 | 11.29% |
| Q4 2020 | 327.59% |
| Q3 2020 | 110.90% |
| Q2 2020 | -316.26% |
| Q1 2020 | -42.25% |
| Q4 2019 | 331.52% |
| Q3 2019 | -162.16% |
| Q2 2019 | -4.52% |
| Q1 2019 | 67291.30% |
| Q4 2018 | -99.86% |
| Q3 2018 | 15.71% |
| Q2 2018 | 18.64% |
| Q1 2018 | 139.86% |
| Q4 2017 | -242.31% |
| Q3 2017 | -11.49% |
| Q2 2017 | 13.53% |
| Q1 2017 | -12.29% |
| Q4 2016 | -6.35% |
| Q3 2016 | -3.82% |
| Q2 2016 | 1.55% |
| Q1 2016 | -20.86% |